Alvogen Recalls Nifedipine Extended-Release Tablets Due to Cross-Contamination
Alvogen, Inc. is recalling Nifedipine Extended-Release Tablets, 60 mg, due to cross-contamination with sorafenib powder found in the manufacturing facility's inlet air duct.
- Product
- Nifedipine Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 07058 USA, NDC 47781-369-01.
- Category
- Drug
- Distribution
- Distributed nationwide